Bhatnagar Anish
CIK 1614821 · CHIEF EXECUTIVE OFFICER · last filed 2026-05-18
Bhatnagar Anish is a CHIEF EXECUTIVE OFFICER who has filed 43 SEC Form 4 insider transactions across 4 companies since 2014. The most recent filing, for SLNO, was dated May 18, 2026. Across all open-market trades the lifetime net is −$67.9M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
4
43
-$67.85M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SLNO | CHIEF EXECUTIVE OFFICER | 0 | $53.01 | $0 | -$67.89M | 31 | 2026-05-18 |
| SOLENO THERAPEUTICS INC (SLNOW) Delisted | President and CEO | — | — | — | $0 | 2 | 2019-01-28 |
| SOLENO THERAPEUTICS INC (CAPNW) Delisted | President and CEO | — | — | — | $0 | 1 | 2017-04-24 |
| SOLENO THERAPEUTICS INC (CAPN.W) Delisted | See Remarks | 83,419 | — | — | $31.7K | 9 | 2016-08-22 |
Recent Filings
43 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-18 | SLNO | Disp (D) | −583,656 | $0 | EDGAR |
| 2026-01-23 | SLNO | Grant (A) | +114,200 | $0 | EDGAR |
| 2025-12-17 | SLNO | Mixed | −107,620 | -$380.6K | EDGAR |
| 2025-03-31 | SLNO | Mixed | −175,286 | -$40.90M | EDGAR |
| 2025-01-23 | SLNO | Grant (A) | +53,900 | $0 | EDGAR |
| 2025-01-06 | SLNO | Sell (S) | −21,091 | -$965.5K | EDGAR |
| 2024-10-03 | SLNO | Sell (S) | −21,633 | -$1.07M | EDGAR |
| 2024-08-30 | SLNO | Sell (S) | −115,004 | -$5.45M | EDGAR |
| 2024-08-07 | SLNO | Sell (S) | −127,344 | -$5.81M | EDGAR |
| 2024-07-19 | SLNO | Grant (A) | +850,000 | $0 | EDGAR |